1-4 of 4
Hong Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer

Free
Timothy R. Donahue, Linh M. Tran, Reginald Hill, Yunfeng Li, Anne Kovochich, Joseph H. Calvopina, Sanjeet G. Patel, Nanping Wu, Antreas Hindoyan, James J. Farrell, Xinmin Li, David W. Dawson, Hong Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1352–1363.
https://doi.org/10.1158/1078-0432.CCR-11-1539
Published: 01 March 2012
View articletitled, Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Open the PDF for Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma

Free
Chintda Santiskulvong, Gottfried E. Konecny, Mirela Fekete, Kuang-Yui Michael Chen, Amer Karam, David Mulholland, Carol Eng, Hong Wu, Min Song, Oliver Dorigo
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2373–2384.
https://doi.org/10.1158/1078-0432.CCR-10-2289
Published: 14 April 2011
View articletitled, Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma
Open the PDF for Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study

Free
Russell J. Schilder, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven L. Decesare, George Lewandowski, Roger B. Lee, Cletus A. Arciero, Hong Wu, Andrew K. Godwin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5539–5548.
https://doi.org/10.1158/1078-0432.CCR-05-0462
Published: 01 August 2005
View articletitled, Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study
Open the PDF for Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study in another window
Journal Articles

Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer

Free
Fadlo R. Khuri, Hong Wu, J. Jack Lee, Bonnie L. Kemp, Reuben Lotan, Scott M. Lippman, Lei Feng, Waun K. Hong, Xiao-Chun Xu
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 861–867.
Published: 01 April 2001
View articletitled, Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer
Open the PDF for Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer in another window